Cofactor Genomics

Cofactor Genomics Focuses on Drug Development in the RNA Research Field. RNA can advance gene therapy by using proteins transcribed from DNA to determine which drugs will be more effective for patients. Currently, the company has obtained CAP and CLIA certifications and launched two products: Pinnacle and Paragon. The former can test nearly 600 RNA biomarkers associated with positive drug responses, while the latter performs RNA-based immunophenotyping assays, which can be widely applied in cancer treatment.